TRAN CAPITAL MANAGEMENT, L.P. Halozyme Therapeutics, Inc. Transaction History

TRAN CAPITAL MANAGEMENT, L.P. portfolio value:

$45.04M
portfolio value

TRAN CAPITAL MANAGEMENT, L.P. quarter portfolio value change:

-10.14%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -25.36% -387.12K shares -22.11M $39.54 1.13M
Q2 2022 share Decrease -1.31% -20.29K shares 5.47M $44 1.52M
Q1 2022 share Increase +3.14% 47.01K shares 1.38M $39.88 1.54M
Q4 2021 share Decrease -0.46% -6.89K shares -985K $40.32 1.49M
Q3 2021 share Increase +11.52% 155.60K shares -60K $40.68 1.50M
Q2 2021 share Decrease -0.17% -2.33K shares 4.92M $45.41 1.35M
Q1 2021 share Increase 0.00% 1.35M shares 56.41M $41.69 1.35M
Q4 2020 share Increase +7.37% 79.86K shares 21.22M $42.71 1.16M
Q3 2020 share Increase +8.24% 82.56K shares 1.63M $26.28 1.08M
Q2 2020 share Increase 0.00% 1.00M shares 26.84M $26.81 1.00M